DOCSLIB.ORG

Atrial and Ventricular Programmed Electrical Stimulation in Patients with Symptomatic Hypertrophic Cardiomyopathy1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Atrial and Ventricular Programmed Electrical Stimulation in Patients with Symptomatic Hypertrophic Cardiomyopathy1 Atrial and ventricular programmed electrical stimulation in patients with symptomatic hypertrophic cardiomyopathy1 William A. Schiavone, D.O Hypertrophic cardiomyopathy is associated with a high inci- Harry M. Lever, M.D. dence of sudden death. Eight patients with symptomatic hyper- James D. Malpney, M.D. trophic cardiomyopathy were studied by atrial and ventricular programmed electrical stimulation in order to correlate the results with symptoms; with arrhythmias documented by continuous 24- hour electrocardiographic monitoring; and with electrocardi- ographic; echocardiographic, and hemodynamic measurements. Atrial stimulation induced sustained atrial tachyarrhythmias in 4 of 6 patients not having sustained atrial fibrillation prior to the study. Only 2 of these 6 patients had sustained atrial tachyarrhyth- mias documented by continuous 24-hour electrocardiographic monitoring; Ventricular stimulation induced sustained ventricular flutter-fibrillation in 1 of 8 patients—the patient with the longest run of unslistained ventricular tachycardia prior to our study. Atrial stimulation better identified patients who could sustain atrial tachyarrhythmias than continuous 24-hour electrocardi- ographic monitoring and demonstrated the hemodynamic consé- quences. Ventricular stimulation identified the patient most vul- nerable to sustained ventricular tachyarrhythmias. Results of atrial and ventricular programmed electrical stimulation may guide patient-management decisions in an attempt to reduce sud- den death due to hypertrophic cardiomyopathy. Index terms: Cardiac pacing, artificial • Electric stimulation • Idiopathic hypertrophic subvalvular stenosis Cleve Clin Q 51:601-609, Winter 1984 1 Department of Cardiology, The Cleveland Clinic Foundation. Submitted for publication Aug 1984; accepted C>ct 1984. sb Hypertrophic cardiomyopathy, a disease of unknown etiology, is characterized by nonspecific symptoms, includ- 0009-8787/84/04/0601/09/$3.25/0 ing exertional dyspnea, angina pectoris, lightheadedness, Copyright © 1984, The Cleveland Clinic and syncope. It is associated with a high incidence of Foundation sudden death.1,2 The best clinical predictors for sudden 601 Downloaded from www.ccjm.org on September 24, 2021. For personal use only. All other uses require permission. 602 Cleveland Clinic Quarterly Vol. 51, No. 4 Table 1. Historical data Patient No. Age Sex Family history Symptoms 1 24 M Brother (patient 4) with hypertrophic cardiomyopa- Palpitations, lightheadedness thy 2 51 M Brother died suddenly (cardiac death) at a young age Lightheadedness, worsening dyspnea on exertion, syn- cope (three times) 3 53 M Twenty-one-year-old son died of hypertrophic cardi- Lightheadedness, angina omyopathy 4 28 M Brother (patient 1) with hypertrophic cadiomyopathy Syncope while driving 5 73 F None Syncope (three times), worsening dyspnea on exertion 6 56 M None Worsening dyspnea on exertion, episodic lightheaded- ness 7 58 F None Syncope, dyspnea on exertion, palpitations 8 64 F None Lightheadedness, palpitatjons, pulmonary edema death are youth, strong family history of sudden thy and correlate the response with clinical symp- death, and progression of symptoms.3,4 Various toms, arrhythmias documented by 24-hour ECG, reports have suggested dynamic outflow obstruc- hemodynamic and anatomic data obtained by tion,5 decreased ventricular diastolic compliance two-dimensional and M-mode echocardiography, with inflow obstruction,2'6,7 and cardiac and left heart catheterization. arrhythmias8,9 alone or in concert to be the un- derlying causes of symptoms and vulnerability to Methods and materials sudden death. From May 1982 through January 1983, 85 We describe our initial experience with atrial patients with hypertrophic cardiomyopathy were and ventricular programmed electrical stimula- seen in the Department of Cardiology at the tion in patients with hypertrophic cardiomyopa- Cleveland Clinic. Only those with progressive Table 2. Initial ECG data Patient Rate P width PR interval QRS duration No. (beats/min) Rhythm (sec) (sec) P axis (sec) QRS axis 53 Sinus 0.14 0.18 -20° 0.11 + 175° 65 Sinus 0.12 0.16 +30° 0.10 +30° 75 Atrial fibrillation 0.10 -30° 68 Sinus 0.12 0.18 +30° 0.11 -75° 53 Sinus 0.14 0.21 + 120° 0.15 LBBB -30° 76 Sinus 0.12 0.19 +50° 0.08 +30° 72 Atrial fibrillation, 0.11 -60° VVI pacer 75 Sinus 0.15 0.24 +75° 0.08 0° Downloaded from www.ccjm.org on September 24, 2021. For personal use only. All other uses require permission. Winter 1984 Electrical Stimulation and hypertrophic cardiomyopathy 603 Table 3. Initial 24-hour ECG data Patient Medications Atrial arrhythmias Ventricular arrthythmias 1 Verapamil (160 q.i.d.) PACs Single VPBs 2 Verapamil (120 q.i.d.) Paroxysmal sustained SVT Trebeled VPBs 3 Propranolol (40 q.i.d.) Sustained atrial fibrillation Paired VPBs 4 Verapamil (80 t.i.d.) None Single VPBs Nadolol (80 q.d.) 5 Verapamil (120 t.i.d.) Paroxysmal sustained atrial fibrillation Single VPBs 6 None None Six-beat unsustained VT 7 Propranolol (20 q.i.d.) Sustained atrial fibrillation Single VPBs, VVI pacer Quinidine (200 q.i.d.) 8 Verapamil (120 t.i.d.) None Five-beat unsustained VT symptoms or a recent history of syncope were Technique of atrial stimulation included in our study. The high right atrium was stimulated with A careful history was obtained and a physical atrial premature impulses at progressively examination was performed. All patients under- shorter coupling intervals until atrial capture was went standard 12-lead and 24-hour ECG and M- lost. The high right atrium was next paced at a mode and two-dimensional echocardiography, as 600-msec cycle length, and a single premature well as left heart catheterization via the Sones extra stimulus was induced at progressively technique. Pressure measurements from the left shorter coupling intervals until loss of capture. ventricular apex, left ventricular outfldw tract, In the absence of an inducible sustained atrial and ascending aorta were taken in sequence at arrhythmia, the atrium was ramp-paced down to rest and after provocation with isoproterenol (2 200-msec cycle length. Induced atrial fibrillation to 8 jug, administered intravenously) or nitro- and atrial flutter were treated in a fashion best glycerin (0.4 mg, administered sublingually). All suited to the patient's hemodynamic status dur- patients underwent selective Coronary arteriog- ing the arrhythmia either by rapid atrial pacing, raphy and left cinè Ventriculography (right ante- by observing spontaneous conversion to sinus rior oblique and left anterior oblique projection). rhythm, or by direct-current cardioversion. Electrophysiologic studies Technique of ventricular stimulation We performed electrophysiologic studies for The right ventricular apex was paced at 600 all patients after sedating the patients with diaze- msec (SI-SI). Premature stimuli (S2) were initi- pam. Right atrial and right ventricular pro- grammed electrical stimulation was conducted in all patients with the use bf two or three multipolar catheters positioned in thè high right atrium and Table 4. Tachyarrhythmias right ventricular apex or in the high right atrium, Supraventricular right ventricular apex, and at the low right Paroxysmal atrium-His bundlé area. Intracardiac electro- Unsustairted (5-30 sec in duration) grams and surface electrocardiograms were si- Sustained (>30 sec in duration) Chronic (present throughout observation period) multaneously recorded via the Gould electro- static recorder. Programmed electrical stimula- Ventricular tion was performed with a Medtronic 5325 stim- Paroxysmal ulator with 1.8-msec rectangular pulses at twice Unsustained (5-20 beats with spontaneous termination) diastolic threshold. Sustained (>20 beats or requiring intervention) Downloaded from www.ccjm.org on September 24, 2021. For personal use only. All other uses require permission. 604 Cleveland Clinic Quarterly Vol. 51, No. 4 Table 5. Echocardiography data Patient Left atrium Septal thickness Resting No. Medications (mm) (mm) SAM 1 Verapamil (160 q.i.d.) 53 32 + 2 Verapamil (120 t.i.d.) 46 20 + 3 Propranolol (40 q.i.d.) 47 22 + Quinidine S04 (300 q.i.d.) 4 None 44 24 - 5 Verapamil (120 t.i.d.) 50 25 + 6 None 44 20 + 7 Propranolol (20 q.i.d.) 51 20 - Quinidine SO., (200 q.i.d.) 8 None 42 30 + SAM = systolic anterior motion of mitral valve. ated after every eighth paced beat, starting in twice this S1-S2 interval. The S3 was moved late diastole and repeating at progressively short- earlier in diastole at 20-msec decrements until it er coupling intervals until induction of a sus- failed to capture. Next, S2 was moved closer to tained ventricular tachyarrhythmia or loss of ven- SI by 10-msec decrements until both S2 and S3 tricular capture. When a sustained ventricular captured. This protocol was followed until either tachyarrhythmia could not be induced, a second induction of a sustained ventricular tachyarrhyth- extra stimulus (S3) was added. From the point of mia or failure of Capture of S2 occurred. If loss of capture of S2, S2 was moved outside the premature stimuli S2 and S3 failed to induce a effective refractory period, and S3 was added at sustained ventricular tachyarrhythmia, rapid ven- Tàble 6. Left heart catheterization data LVOT gradient (mm Hg) Patient No, Medications CAD MR Resting Provoked 1 Verapamil (160 q.i.d.) - - 25 45 I 2 Verapamil (120 t.i.d.) - - 30 120 I 3 Propranolol (40 q.i.d.) - - 30 1201 Quinidine S04 (300 q.i.d.) 4 None +25% right coronary artery - 0 70 I 5 Verapamil (120 t.i.d.) - Severe 80 100 N 6 None +30% right coronary
Load more

Recommended publications
  • Follow-Up of 134 Pediatric Patients with Wolff-Parkinson-White Pattern: Natural Outcome and Medical Treatment
    ORIGINAL ARTICLE Follow-up of 134 Pediatric Patients with Wolff-Parkinson-White Pattern: Natural Outcome and Medical Treatment AMALIA N. STEFANI, GABRIELA R. DAL FABBRO, MARÍA J. BOSALEH, ROBERTH VÁSQUEZ, GUSTAVO A. COSTA, RICARDO SPERANZA, JORGE L. GENTILE, CLAUDIO DE ZULOAGAMTSAC Received: 01/03/2013 ABSTRACT Accepted: 01/03/2013 Address for reprints: Objective Amalia N. Stefani The aim of the study was to evaluate the outcome of a pediatric population with Almafuerte 1722 ventricular pre-excitation pattern, supraventricular tachycardia, atrial fibrillation, (1650) San Martín, cardiomyopathies, mortality and medical treatment. Pcia. de Buenos Aires e-mail: [email protected] Methods From 1976 to 2011, a descriptive observational study was conducted on patients with ventricular pre-excitation in the electrocardiogram. All patients underwent an echocardiogram, 101(75.3%) Holter monitoring, and 69 (51.5%) an ergometric test. Radiofrequency ablation was performed in selected patients. Data were expressed as mean and standard deviation. Results The study population consisted of 134 patients; 80 (59.7%) were male. Age at diag- nosis ranged from 2 days to 18 years (mean 6.5±5 years). Clinical follow-up lasted 1 month to 20 years (mean 3.6±3.9 years). Thirty five patients (26.1%) consulted for supraventricular tachycardia, 16 (11.9%) for ventricular pre-excitation, and the remaining 83 patients (61.9%) for other abnormalities. Seventy-six patients (56.7%) had left conduction pathway and 3 patients double conduction pathway. Sixteen pa- tients (11.9%) presented supraventricular tachycardia during follow-up. Overall, 51 patients (38%) had orthodromic tachycardia at 6.3±5.8 years, 10 patients during the neonatal period.
    [Show full text]
  • ICD-9-ICD-10 Codes for Cardiology
    ICD-9-ICD-10 Codes for Cardiology ICD-9 Code ICD-10 Code(s) ICD-10 Descrption(s) Atrial Fibrillation and Flutter 427.31, 427.32 I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter I48.4 Atypical atrial flutter I48.91* Unspecified atrial fibrillation I48.92* Unspecified atrial flutter Cardiac Arrhythmias (Other) 427.41, 427.42, 427.60, 427.61, 427.69, 427.81, 427.89, 427.9 I49.01 Ventricular fibrillation I49.02 Ventricular flutter I49.1 Atrial premature depolarization I49.2 Junctional premature depolarization I49.3 Ventricular premature depolarization I49.40 Unspecified premature depolarization I49.49 Other premature depolarization I49.5 Sick sinus syndrome I49.8 Other specified cardiac arrhythmias I49.9* Cardiac arrhythmia, unspecified Chest Pain 411.1, 413.1, 413.9, 786.50 to 786.59 range I20.0 Unstable angina I20.1 Angina pectoris with documented spasm I20.8 Other forms of angina pectoris I20.9 Angina pectoris, unspecified R07.1 Chest pain on breathing R07.2 Precordial pain R07.81 Pleurodynia R07.82 Intercostal pain R07.89 Other chest pain R07.9* Chest pain, unspecified Heart Failure 428.0, 428.1, 428.20 to 428.23 range, 428.30 to 428.33 range, 428.40 to 428.43 range, 428.9 I50.1 Left ventricular failure I50.20* Unspecified systolic (congestive) heart failure I50.21 Acute systolic (congestive) heart failure I50.22 Chronic systolic (congestive) heart failure I50.23 Acute on chronic systolic (congestive) heart failure I50.30* Unspecified diastolic (congestive)
    [Show full text]
  • Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3054 Date: August 29, 2014 Change Request 8803
    Department of Health & CMS Manual System Human Services (DHHS) Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 3054 Date: August 29, 2014 Change Request 8803 SUBJECT: Ventricular Assist Devices for Bridge-to-Transplant and Destination Therapy I. SUMMARY OF CHANGES: This Change Request (CR) is effective for claims with dates of service on and after October 30, 2013; contractors shall pay claims for Ventricular Assist Devices as destination therapy using the criteria in Pub. 100-03, part 1, section 20.9.1, and Pub. 100-04, Chapter 32, sec. 320. EFFECTIVE DATE: October 30, 2013 *Unless otherwise specified, the effective date is the date of service. IMPLEMENTATION DATE: September 30, 2014 Disclaimer for manual changes only: The revision date and transmittal number apply only to red italicized material. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual is not updated) R=REVISED, N=NEW, D=DELETED-Only One Per Row. R/N/D CHAPTER / SECTION / SUBSECTION / TITLE D 3/90.2.1/Artifiical Hearts and Related Devices R 32/Table of Contents N 32/320/Artificial Hearts and Related Devices N 32/320.1/Coding Requirements for Furnished Before May 1, 2008 N 32/320.2/Coding Requirements for Furnished After May 1, 2008 N 32/320.3/ Ventricular Assist Devices N 32/320.3.1/Postcardiotomy N 32/320.3.2/Bridge-To -Transplantation (BTT) N 32/320.3.3/Destination Therapy (DT) N 32/320.3.4/ Other N 32/320.4/ Replacement Accessories and Supplies for External Ventricular Assist Devices or Any Ventricular Assist Device (VAD) III.
    [Show full text]
  • Arrhythmias in Two Patients with Left Ventricular Bypass Transplants'
    Br Heart J: first published as 10.1136/hrt.38.7.725 on 1 July 1976. Downloaded from British Heart Journal, 1976, 38, 725-731. Arrhythmias in two patients with left ventricular bypass transplants' Brian M. Kennelly, Peter Corte, Jacques Losman, and Christiaan N. Barnard From the Cardiac Clinic and Department of Cardiothoracic Surgery, Groote Schuur Hospital and the Departments of Medicine and Surgery, University of Cape Town, South Africa Two patients who underwvent left ventricular bypass transplants are described. Both patients sustained post- operative rhythm disturbances of their own hearts during sinus rhythm of the donor hearts. Illustrative examples of atrialflutter, ventricular flutter, ventricular fibrillation, blocked atrial extrasystoles, and double ventricular parasystole in the recipient hearts are presented. The patients tolerated all these arrhythmias well during uninterrupted sinus rhythm in the donor heart. The problems in interpretation of arrhythmias in the presence of two hearts are discussed. [DONOR I IRECIPIENTI Sv C..AOT A ;PULMONARY ARRY http://heart.bmj.com/ RIGHTATRIU_gXARA t,.Y APPENDAGE R.V R.V on September 28, 2021 by guest. Protected copyright. FIG. 1 Position of donor and recipient hearts in anteroposterior view with relevant anasta- moses (Barnard and Losman (1975). Reprinted with permission of South African Medical Journal). The purpose of this report is to illustrate some of right lung and in the right cardiophrenic angle. the bizarre electrocardiograms resulting from Both venae cavae of the donor heart are ligated and cardiac transplantation in man where the recipient the donor right ventricle pumps only its coronary heart is left in situ. The surgical technique was sinus venous return into the recipient's right described in detail by Barnard and Losman (1975).
    [Show full text]
  • Short-Term Exposure to Air Pollution and Cardiac Arrhythmia: a Meta-Analysis and Systematic Review
    Int. J. Environ. Res. Public Health 2016, 13, doi:10.3390/ijerph13070642 S1 of S7 Supplementary Materials: Short-Term Exposure to Air Pollution and Cardiac Arrhythmia: A Meta-Analysis and Systematic Review Xuping Song, Yu Liu, Yuling Hu, Xiaoyan Zhao, Jinhui Tian, Guowu Ding and Shigong Wang Figure S1. Flow chart of the literature screening process. Int. J. Environ. Res. Public Health 2016, 13, doi:10.3390/ijerph13070642 S2 of S7 Figure S2. Association between particulate and gaseous components with hospitalization or mortality due to arrhythmia. Int. J. Environ. Res. Public Health 2016, 13, doi:10.3390/ijerph13070642 S3 of S7 Table S1. Search Strategy for PubMed. No. Search Strategy air pollution*/or air pollutant*/or air polluted/or air contamination*/or atmosphere pollution*/or atmosphere pollutant*/ or atmosphere contamination*/or atmospheric pollution*/or atmospheric #1 pollutant*/or atmospheric contamination*/or “particulate matter”/or “PM10”/or “PM2.5”/or ozone/ or “O3”/or “carbon monoxide”/or carbonmonoxide/or “CO“/or “nitrogen dioxide”/or “NO2”/or “sulphur dioxide”/or “sulphur dioxyde”/or “sulfurous anhydride“/or “SO2”.ti,ab. Air Pollution/or Particulate Matter/or Ozone/or Carbon Monoxide/or Nitrogen Dioxide/or Sulfur #2 Dioxide.sh. #3 or/1,2 #4 arrhythmia* /or dysrhythmia* /or “CA”.ti,ab. #5 Arrhythmias, Cardiac.sh. “Sick Sinus Syndrome”/or “SSS”/or “Sick Sinus Node Syndrom”/or Sinus Node Dysfunction*/or #6 Sinus Node Disease*/or Sinus Arrest*.ti,ab. #7 Arrhythmia, Sinus/or Sick Sinus Syndrome/or Sinus Arrest, Cardiac.sh. #8 atrial fibrillation*/or auricular fibrillation*/or “AF".ti,ab. #9 Atrial Fibrillation.sh.
    [Show full text]
  • A Closer Look: Documentation and Coding for Cardiac Conditions
    A Closer Look: Documentation and Coding for Cardiac Conditions Heart disease is a broad term used to describe a range of diseases that affect the heart. The various diseases that fall under the umbrella of heart disease include diseases of the heart and blood vessels. The term “heart disease" is often used interchangeably with "cardiovascular disease." Cardiovascular disease generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart attack, angina or stroke. Other heart conditions, such as infections and conditions that affect the heart's muscle, valves or beating rhythm are also considered forms of heart disease. All types of heart disease share common traits, but they also have key differences. The goal of this article is to spend some time looking at documentation and diagnosis coding for conditions that fall under the cardiac conditions umbrella to achieve accurate and compliant practices. Dysrhythmias Cardiac dysrhythmia (also known as arrhythmia or irregular heartbeat) is any of a group of conditions in which the electrical activity of the heart is irregular or is faster or slower than normal. The following are some common types of arrhythmia. Tachycardia is an abnormally fast resting heart rate, usually exceeding 100 beats per minute. Supraventricular tachycardia (SVT) is a burst of rapid heartbeats occurring in the top portion of the ventricles. Paroxysmal means the arrhythmia begins and ends suddenly. If the documentation is unclear, the Physician may need to be queried for clarification. Ventricular tachycardia is an abnormal electrical impulse that originates in the ventricles. It may be documented as nonsustained (lasting for less than 30 seconds) or sustained.
    [Show full text]
  • Premature Ventricular Contraction Increases the Risk of Heart Failure
    www.nature.com/scientificreports OPEN Premature ventricular contraction increases the risk of heart failure and ventricular tachyarrhythmia Yun Gi Kim1,3, Yun Young Choi1,3, Kyung‑Do Han2, Kyoung Jin Min1, Ha Young Choi1, Jaemin Shim1, Jong‑Il Choi1* & Young‑Hoon Kim1 Premature ventricular contraction (PVC), a common arrhythmia afecting 1–2% of the general population, has been considered to have a benign clinical course. However, people with PVC often develop heart failure and ventricular arrhythmias such as ventricular tachycardia. We aimed to clarify the risk of heart failure and lethal ventricular arrhythmias in people with PVC. The Korean National Health Insurance Service database was used for this study. People who underwent nationwide health check‑ups in 2009 were enrolled in this study and clinical follow‑up data until December 2018 were analyzed. Newly diagnosed PVC in 2009 (≥ 1 inpatient or outpatient claim) were identifed and cumulative incidence of heart failure (≥ 1 inpatient claim) and ventricular arrhythmias (≥ 1 inpatient or outpatient claim) were compared. A total of 4515 people were frst diagnosed with PVC in 2009 among 9,743,582 people without prior history of PVC, heart failure, or ventricular arrhythmias. People with newly diagnosed PVC in 2009 had a signifcantly higher incidence of heart failure compared to those without PVC [adjusted hazard ratio (HR) 1.371; 95% confdence interval (CI) 1.177–1.598; p < 0.001]. Signifcant interaction was observed between age and PVC with young age people at greater risk of developing heart failure for having PVC. The incidence of ventricular arrhythmia was also signifcantly increased in people with PVC (HR 5.588; 95% CI 4.553–6.859; p < 0.001).
    [Show full text]
  • EPISODIC SYNCOPE CAUSED by VENTRICULAR FLUTTER in a TIGER (PANTHERA TIGRIS) Author(S): Daniel M
    EPISODIC SYNCOPE CAUSED BY VENTRICULAR FLUTTER IN A TIGER (PANTHERA TIGRIS) Author(s): Daniel M. DeLillo , M.S., D.V.M., Sophy A. Jesty , D.V.M., Dipl. A.C.V.I.M. and Marcy J. Souza , D.V.M., M.P.H., Dipl. A.B.V.P. (Avian), Dipl. A.C.V.P.M. Source: Journal of Zoo and Wildlife Medicine, 44(2):500-504. 2013. Published By: American Association of Zoo Veterinarians DOI: http://dx.doi.org/10.1638/2012-0203.1 URL: http://www.bioone.org/doi/full/10.1638/2012-0203.1 BioOne (www.bioone.org) is a nonprofit, online aggregation of core research in the biological, ecological, and environmental sciences. BioOne provides a sustainable online platform for over 170 journals and books published by nonprofit societies, associations, museums, institutions, and presses. Your use of this PDF, the BioOne Web site, and all posted and associated content indicates your acceptance of BioOne’s Terms of Use, available at www.bioone.org/page/ terms_of_use. Usage of BioOne content is strictly limited to personal, educational, and non-commercial use. Commercial inquiries or rights and permissions requests should be directed to the individual publisher as copyright holder. BioOne sees sustainable scholarly publishing as an inherently collaborative enterprise connecting authors, nonprofit publishers, academic institutions, research libraries, and research funders in the common goal of maximizing access to critical research. Journal of Zoo and Wildlife Medicine 44(2): 500–504, 2013 Copyright 2013 by American Association of Zoo Veterinarians EPISODIC SYNCOPE CAUSED BY VENTRICULAR FLUTTER IN A TIGER (PANTHERA TIGRIS) Daniel M.
    [Show full text]
  • ICD-10: Clinical Concepts for Cardiology
    ICD-10 Clinical Concepts for Cardiology ICD-10 Clinical Concepts Series Common Codes Clinical Documentation Tips Clinical Scenarios ICD-10 Clinical Concepts for Cardiology is a feature of Road to 10, a CMS online tool built with physician input. With Road to 10, you can: l Build an ICD-10 action plan customized l Access quick references from CMS and for your practice medical and trade associations l Use interactive case studies to see how l View in-depth webcasts for and by your coding selections compare with your medical professionals peers’ coding To get on the Road to 10 and find out more about ICD-10, visit: cms.gov/ICD10 roadto10.org ICD-10 Compliance Date: October 1, 2015 Official CMS Industry Resources for the ICD-10 Transition www.cms.gov/ICD10 1 Table Of Contents Common Codes • Abnormalities of • Hypertension Heart Rhythm • Nonrheumatic • Atrial Fibrillation and Flutter Valve Disorders • Cardiac Arrhythmias (Other) • Selected Atherosclerosis, • Chest Pain Ischemia, and Infarction • Heart Failure • Syncope and Collapse Clinical Documentation Tips • Acute Myocardial • Atheroclerotic Heart Disease Infraction (AMI) with Angina Pectoris • Hypertension • Cardiomyopathy • Congestive Heart Failure • Heart Valve Disease • Underdosing • Arrythmias/Dysrhythmia Clinical Scenarios • Scenario 1: Hypertension/ • Scenario 4: Subsequent AMI Cardiac Clearance • Scenario: CHF and • Scenario 2: Syncope Pulmonary Embolism Example • Scenario 3: Chest Pain Common Codes ICD-10 Compliance Date: October 1, 2015 Abnormalities of Heart Rhythm (ICD-9-CM 427.81, 427.89, 785.0, 785.1, 785.3) R00.0 Tachycardia, unspecified R00.1 Bradycardia, unspecified R00.2 Palpitations R00.8 Other abnormalities of heart beat R00.9* Unspecified abnormalities of heart beat *Codes with a greater degree of specificity should be considered first.
    [Show full text]
  • ECG Made Easy Part 2 – ECG Quiz
    ECG made easy Part 2 – ECG Quiz • Presented by: • Dr Randall Hendriks, Interventional Cardiologist – Western Australia 1 ? Axis 1. Left 2. Right 3. Indeterminate ? Axis 1. Left 2. Right 3. Indeterminate ? Axis 1. Left 2. Right 3. Indeterminate Page 4 ? Axis 1. Left 2. Right 3. Indeterminate Page 5 ? Axis 1. Left 2. Right 3. Indeterminate Page 6 ? Axis 1. Left 2. Right 3. Indeterminate Standard limb lead reversal! Page 7 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 8 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 9 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 10 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 11 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 12 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 13 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 14 Tachycardia 1. Atrial fibrillation 2. Atrial flutter 3. SVT 4. Sinus tachycardia 5. Junctional Page 15 Tachycardia 1. Atrial flutter 2. Atrial fibrillation 3. SVT 4. Sinus tachycardia 5. Junctional Page 16 Tachycardia 1. Atrial flutter 2. Atrial fibrillation 3. SVT 4. Sinus tachycardia 5. Junctional Page 17 Bradycardia 1. Sinus bradycardia 2. First degree AV block 3. Mobitz Type I (Wenckebach) 4. Mobitz Type 2 5. Complete heart block Page 18 Bradycardia 1. Sinus bradycardia 2.
    [Show full text]
  • Middle-Aged Woman with Delayed Diagnosis of Severe Mitro-Aortic Valvular Rheumatic Heart Disease Following Tachyarrhythmic Event
    Middle-aged woman with delayed diagnosis of severe mitro-aortic Valvular rheumatic heart disease following tachyarrhythmic event Mulher de média idade com diagnóstico tardio de valvulopatia mitro-aórtica remumática Andrés Ricardo Pérez-Riera M.D. Ph.D. Physician of Hospital do Coração (HCor) - Sao Paulo-Brazil In charge of Electro-vectorcardiogram sector – Cardiology Discipline –ABC Faculty of Medicine –ABC Foundation - Santo André –São Paulo – Brazil. [email protected] Case report A 41-year-old Caucasian woman, housewife, natural of the countryside of São Paulo Brazil, from a low socioeconomic background presented in our clinical consultation after internment 2 Month ago consequence of tachyarrithtymic event At this time, her only symptom was intermittent palpitations. She had no recollection of previous rheumatic fever. History of Present Illness (HPI) She refer the last Month presented fatigue, especially during times of increased physical activity, progressive shortness of breath especially with exertion or when lie down a dry cough presented at rest and unique fast regular palpitation episode that its motives emergency internment and intra-hospitalar treatment with electric cardioversion and use of intravenous drugs The patient denied fever, chest pain, or other systemic symptoms. She has no recollection of any previous symptoms or antecedent of repetitive streptococcal throat infections, murmurs or joints pain in the pass. There was no personal or familial history of cardiovascular disease or rheumatic fever picture. Physical She was breathing well, acianotic, without fever and cored. She was in sinus rhythm, BP: normal systolic blood pressure and low diastolic=140/30-0 mmHg with Watson's water hammer pulse.
    [Show full text]
  • Supraventricular Tachycardia: Diagnosis and Current Acute Management
    Archives ofDisease in Childhood 1991; 66: 647-652 647 PERSONAL PRACTICE Arch Dis Child: first published as 10.1136/adc.66.5.647 on 1 May 1991. Downloaded from Supraventricular tachycardia: diagnosis and current acute management Janice A Till, Elliot A Shinebourne There is a small but potentially avoidable inci- dence of death associated with childhood supra- ventricular tachycardia.1 2 The time of greatest risk is when the child presents for the first time and requires therapeutic intervention. Infants and children tolerate arrhythmias less well than adults as they are more dependent on heart rate for cardiac output and have less reserve.3 4 They are also at risk from drugs given as treatment.5 We discuss our current acute man- agement of supraventricular tachycardia. Diagnosis Between 30 and 40% of children who present with supraventricular tachycardia do so within the first few weeks of life. Their presentation is variable. Supraventricular tachycardia can be the cause of unexplained hydrops of the fetus or Figure I An electrocardiogram recordedfrom a I week old can result in sudden profound cardiovascular neonate with atrioventricular re-entry tachycardia showing collapse in the newborn period.6 More usually the typicalpattern with a P' wave almost midway between neonates and small infants will present with QRS complexes. symptoms of increasing tachypnoea, poor feed- http://adc.bmj.com/ ing, and pallor which have developed over a few days. Occasionally supraventricular tachycardia is intermittent and a strong index of suspicion Classification of supraventricular tachycardia must be maintained if the diagnosis is not to be Junctional tachycardias missed.
    [Show full text]